Tracking progress on antimicrobial resistance by the quadripartite country self-assessment survey (TrACSS) in G7 countries, 2017-2023: opportunities and gaps.

Autor: Sabbatucci M; Directorate General Health Prevention, Communicable Diseases and International Prophylaxis, Ministry of Health, Rome 00144, Italy. Electronic address: michela.sabbatucci@iss.it., Ashiru-Oredope D; HCAI, Fungal, AMR, AMU & Sepsis Division, United Kingdom Health Security Agency, London NW9 5EQ, United Kingdom; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, United Kingdom. Electronic address: diane.ashiru-oredope@ukhsa.gov.uk., Barbier L; French Ministry of Ecological Transition and Territorial Cohesion, La Défense 92055, France. Electronic address: laura.barbier@developpement-durable.gouv.fr., Bohin E; French Ministry of Agriculture and Food Sovereignty, Paris 75015, France. Electronic address: elisa.bohin@agriculture.gouv.fr., Bou-Antoun S; HCAI, Fungal, AMR, AMU & Sepsis Division, United Kingdom Health Security Agency, London NW9 5EQ, United Kingdom. Electronic address: Sabine.BouAntoun@ukhsa.gov.uk., Brown C; HCAI, Fungal, AMR, AMU & Sepsis Division, United Kingdom Health Security Agency, London NW9 5EQ, United Kingdom; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, United Kingdom. Electronic address: colin.brown@ukhsa.gov.uk., Clarici A; Federal Ministry of Health, Division 'One Health, Antimicrobial Resistance', Berlin 10117, Germany. Electronic address: alexandra.clarici@bmg.bund.de., Fuentes C; French Ministry of Agriculture and Food Sovereignty, Paris 75015, France. Electronic address: claire.fuentes@agriculture.gouv.fr., Goto T; International Affairs Division, Minister's Secretariat, Ministry of Health, Labour and Welfare, Tokyo 100-8916, Japan. Electronic address: gotou-takahiro@mhlw.go.jp., Maraglino F; Directorate General Health Prevention, Communicable Diseases and International Prophylaxis, Ministry of Health, Rome 00144, Italy. Electronic address: f.maraglino@sanita.it., Morin J; French Ministry of Health and Prevention, Paris 75007, France. Electronic address: julien.morin@sante.gouv.fr., Rönnefahrt I; Federal Ministry for the Environment, Nature Conservation, Nuclear Safety and Consumer Protection, Division 'Plant Protection Products, Biocides, Medicinal Products', Berlin 10117, Germany. Electronic address: ines.roennefahrt@bmuv.bund.de., Sanwidi A; Federal Ministry of Food and Agriculture, Division 'Veterinary medicines, residues of pharmacologically active substances in food', Bonn 53123, Germany. Electronic address: andrea.sanwidi@bmel.bund.de., Triggs-Hodge C; HCAI, Fungal, AMR, AMU & Sepsis Division, United Kingdom Health Security Agency, London NW9 5EQ, United Kingdom. Electronic address: carry.triggshodge@ukhsa.gov.uk., Vitiello A; Directorate General Health Prevention, Communicable Diseases and International Prophylaxis, Ministry of Health, Rome 00144, Italy. Electronic address: a.vitiello@sanita.it., Zovi A; Directorate General for Hygiene, Food Safety and Nutrition, Ministry of Health, Rome 00144, Italy. Electronic address: a.zovi@sanita.it., Gelormini M; Control of Antimicrobial Resistance Programme, World Health Organization Regional Office for Europe, Copenhagen, Denmark. Electronic address: gelorminim@who.int., Lo Fo Wong D; Control of Antimicrobial Resistance Programme, World Health Organization Regional Office for Europe, Copenhagen, Denmark. Electronic address: lofowongd@who.int.

Publikováno v: Pharmacological research [Pharmacol Res] 2024 Jun; Vol. 204, pp. 107188. Date of Electronic Publication: 2024 May 03.

COVID-19 therapeutics: stewardship in England and considerations for antimicrobial resistance.

Autor: Bou-Antoun S; Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, United Kingdom Health Security Agency (UKHSA), London, UK., Rokadiya S; Genomics Public Health Analysis (GPHA), United Kingdom Health Security Agency (UKHSA), London, UK., Ashiru-Oredope D; Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, United Kingdom Health Security Agency (UKHSA), London, UK., Demirjian A; Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, United Kingdom Health Security Agency (UKHSA), London, UK.; Department of Paediatric Infectious Diseases & Immunology, Evelina London Children's Hospital, London, UK.; Faculty of Life Sciences & Medicine, King's College London, London, UK., Sherwood E; Clinical and Emerging Infections (CEI), United Kingdom Health Security Agency (UKHSA), London, UK., Ellaby N; Genomics Public Health Analysis (GPHA), United Kingdom Health Security Agency (UKHSA), London, UK., Gerver S; Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, United Kingdom Health Security Agency (UKHSA), London, UK., Grossi C; COVID-19 Rapid Evidence Service Public Health Advice, Guidance and Expertise (PHAGE), UK Health Security Agency, London NW9 5EQ, UK., Harman K; COVID-19 Vaccines and Applied Epidemiology Division, UK Health Security Agency, London NW9 5EQ, UK., Hartman H; Genomics Public Health Analysis (GPHA), United Kingdom Health Security Agency (UKHSA), London, UK., Lochen A; Tuberculosis (TB), Acute Respiratory, Zoonoses, Emerging and Travel infections Division, UK Health Security Agency, London NW9 5EQ, UK., Ragonnet-Cronin M; Genomics Public Health Analysis (GPHA), United Kingdom Health Security Agency (UKHSA), London, UK.; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.; Department of Ecology and Evolution, University of Chicago, Chicago, IL, USA., Squire H; Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, United Kingdom Health Security Agency (UKHSA), London, UK., Sutton JM; Research and Evaluation, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK.; Institute of Pharmaceutical Sciences, King's College London, London, UK., Thelwall S; COVID-19 Vaccines and Applied Epidemiology Division, UK Health Security Agency, London NW9 5EQ, UK., Tree J; Research and Evaluation, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK., Bahar MW; Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Oxford, UK., Stuart DI; Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Oxford, UK.; Diamond Light Source Ltd, Harwell Science & Innovation Campus, Didcot, UK., Brown CS; Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, United Kingdom Health Security Agency (UKHSA), London, UK., Chand M; Genomics Public Health Analysis (GPHA), United Kingdom Health Security Agency (UKHSA), London, UK., Hopkins S; Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, United Kingdom Health Security Agency (UKHSA), London, UK.

Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2023 Nov 23; Vol. 78 (Suppl 2), pp. ii37-ii42.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Respiratory antibacterial prescribing in primary care and the COVID-19 pandemic in England, winter season 2020-21.

Autor: Andrews A; HCAI, Fungal, AMR, AMU & Sepsis Division, UK Health Security Agency, London NW9 5EQ, UK.; National Institute for Health Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford OX3 9DU, UK.; Nuffield Department of Medicine, University of Oxford, Oxford OX3 9DU, UK., Bou-Antoun S; HCAI, Fungal, AMR, AMU & Sepsis Division, UK Health Security Agency, London NW9 5EQ, UK.; National Institute for Health Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at Imperial College London, London W12 0NN, UK., Guy R; HCAI, Fungal, AMR, AMU & Sepsis Division, UK Health Security Agency, London NW9 5EQ, UK., Brown CS; HCAI, Fungal, AMR, AMU & Sepsis Division, UK Health Security Agency, London NW9 5EQ, UK.; National Institute for Health Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at Imperial College London, London W12 0NN, UK., Hopkins S; HCAI, Fungal, AMR, AMU & Sepsis Division, UK Health Security Agency, London NW9 5EQ, UK.; National Institute for Health Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford OX3 9DU, UK.; National Institute for Health Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at Imperial College London, London W12 0NN, UK., Gerver S; HCAI, Fungal, AMR, AMU & Sepsis Division, UK Health Security Agency, London NW9 5EQ, UK.; National Institute for Health Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford OX3 9DU, UK.; National Institute for Health Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at Imperial College London, London W12 0NN, UK.

Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2022 Feb 23; Vol. 77 (3), pp. 799-802.

Descriptive epidemiology of Escherichia coli bacteraemia in England, April 2012 to March 2014.

Autor: Bou-Antoun, S., Davies, J., Guy, R., Johnson, A. P., Sheridan, E. A., Hope, R. J.

Publikováno v: Eurosurveillance (15607917); 9/1/2016, Vol. 21 Issue 35, p9-17, 9p, 2 Charts, 3 Graphs, 1 Map